home / stock / bsem / bsem news

BSEM News and Press, BioStem Technologies Inc From 10/02/25

Stock Information
Company Name: BioStem Technologies Inc
Stock Symbol: BSEM
Market: OTC
Website: biostemtechnologies.com
Menu
BSEM BSEM Quote BSEM Short BSEM News BSEM Articles BSEM Message Board
Get BSEM Alerts

News, Short Squeeze, Breakout and More Instantly...
BSEM - BioStem Technologies Expands Partnership with the Florida Panthers as a Sponsor for the 13th Season of the "Heroes Among Us" Program

Program has honored more than 500 members of the military since its inception Sponsorship honors both local military veterans and healthcare professionals POMPANO BEACH, Fla., Oct. 02, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company foc...
BSEM - BioStem Technologies, Inc. (BSEM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

2025-09-10 18:15:43 ET BioStem Technologies, Inc. (BSEM) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 3:20 PM EDT... Read the full article on Seeking Alpha For further details see: BioStem Technologies, Inc. (BSEM) Presents At Morgan Stanley 23r...

BSEM - BioStem Showcasing its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Fall Meeting

Company co-exhibiting with strategic partner Venture Medical, LLC, highlighting collaborative innovation in chronic wound care management Three scientific posters feature BioStem’s proprietary allograft portfolio POMPANO BEACH, Fla., Sept. 05, 2025 (GLOBE NEWSWIRE) -- BioSt...

BSEM - BioStem Technologies to Present at Two Upcoming Investor Conferences

POMPANO BEACH, Fla., Sept. 02, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announced that Company management will present ...
BSEM - BioStem Technologies, Inc. (BSEM) Q2 2025 Earnings Call Transcript

2025-08-14 20:55:48 ET BioStem Technologies, Inc. (BSEM) Q2 2025 Earnings Conference Call August 14, 2025 04:30 PM ET Company Participants Adam Holdsworth - Corporate Participant Brandon Poe - Corporate Participant Jason V. Matuszewski - CEO, President, Secretary...

BSEM - BioStem reports Q2 prelim revenue of $49.3M

2025-08-14 16:59:47 ET More on BioStem Technologies BioStem Technologies: Huge Growth, Poised To Help Wound Care Field Seeking Alpha’s Quant Rating on BioStem Technologies Historical earnings data for BioStem Technologies Financial information for BioS...

BSEM - BioStem Technologies GAAP EPS of -$0.03 misses by $0.25, revenue of $49.29M misses by $28.93M

2025-08-14 16:22:31 ET More on BioStem Technologies BioStem Technologies: Huge Growth, Poised To Help Wound Care Field Seeking Alpha’s Quant Rating on BioStem Technologies Historical earnings data for BioStem Technologies Financial information for BioS...
BSEM - BioStem Technologies Reports Preliminary Second Quarter 2025 Financial Results

POMPANO BEACH, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (“BioStem” or the “Company”) (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound c...

BSEM - BioStem Technologies Appoints Brandon Poe as Chief Financial Officer

POMPANO BEACH, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (“BioStem” or the “Company”) (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound c...

BSEM - Expected US Company Earnings on Thursday, August 14th, 2025

Century Therapeutics Inc. (IPSC) is expected to report $-0.38 for Q2 2025 Birchtech Corp Com (BCHT) is expected to report for Q2 2025 Cellectar Biosciences Inc. (CLRB) is expected to report $-3.6 for Q2 2025 Acuren Corporation (TIC) is expected to report for quarter end 2025-06-30 ...
Previous 10 Next 10